nasdaq:slp
|
95827
|
Apr 21st, 2024 12:00AM
|
Simulations Plus, Inc.
|
9.4K
|
154.00
|
Open
|
|
Apr 21st, 2024 03:16AM
|
Apr 21st, 2024 03:16AM
|
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
For more information visit us at www.simulations-plus.com
|
Open
|
Modeling & Simulation Software and Consulting Services, ADME-Tox Screening, Data Mining, Library Design, PBPK/PD Modeling & IVIVCs, Drug-Drug Interactions & Virtual Population Trials, Nonlinear Metabolism/Transport &Metabolite Tracking, PK/PD Modeling and Simulation, PBPK Modeling & Simulation, Drug Development, Regulatory Writing, Quantitative Systems Pharmacology, Clinical Pharmacology, Model-based Drug Discovery & Development, ADMET Property Estimation, QSAR Modeling & Analysis, QSP/QST modeling, On-site Training, Quantitative Systems Toxicology, End-to-End in silico solutions, Pharmacometrics, NCA PK Reporting, Compartmental PK Reporting, Drug-Induced-Liver-Injury , Cloud-based Web Application KIWI, Non-Alcholic Fatty Liver Disease, in vitro Dissolution Method Design, in vitro Permeability, FREE Chemical Sketching Software, and PBTK Modeling & Analysis/Simulation
|
Open
|
42505 10th Street West
|
Lancaster
|
California
|
US
|
93534
|
|
Simulations Plus
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:slp
|
95827
|
Apr 20th, 2024 12:00AM
|
Simulations Plus, Inc.
|
9.4K
|
154.00
|
Open
|
|
Apr 20th, 2024 12:04AM
|
Apr 20th, 2024 05:39PM
|
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
For more information visit us at www.simulations-plus.com
|
Open
|
Modeling & Simulation Software and Consulting Services, ADME-Tox Screening, Data Mining, Library Design, PBPK/PD Modeling & IVIVCs, Drug-Drug Interactions & Virtual Population Trials, Nonlinear Metabolism/Transport &Metabolite Tracking, PK/PD Modeling and Simulation, PBPK Modeling & Simulation, Drug Development, Regulatory Writing, Quantitative Systems Pharmacology, Clinical Pharmacology, Model-based Drug Discovery & Development, ADMET Property Estimation, QSAR Modeling & Analysis, QSP/QST modeling, On-site Training, Quantitative Systems Toxicology, End-to-End in silico solutions, Pharmacometrics, NCA PK Reporting, Compartmental PK Reporting, Drug-Induced-Liver-Injury , Cloud-based Web Application KIWI, Non-Alcholic Fatty Liver Disease, in vitro Dissolution Method Design, in vitro Permeability, FREE Chemical Sketching Software, and PBTK Modeling & Analysis/Simulation
|
Open
|
42505 10th Street West
|
Lancaster
|
California
|
US
|
93534
|
|
Simulations Plus
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:slp
|
95827
|
Apr 19th, 2024 12:00AM
|
Simulations Plus, Inc.
|
9.3K
|
153.00
|
Open
|
|
Apr 19th, 2024 04:39AM
|
Apr 19th, 2024 04:39AM
|
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
For more information visit us at www.simulations-plus.com
|
Open
|
Modeling & Simulation Software and Consulting Services, ADME-Tox Screening, Data Mining, Library Design, PBPK/PD Modeling & IVIVCs, Drug-Drug Interactions & Virtual Population Trials, Nonlinear Metabolism/Transport &Metabolite Tracking, PK/PD Modeling and Simulation, PBPK Modeling & Simulation, Drug Development, Regulatory Writing, Quantitative Systems Pharmacology, Clinical Pharmacology, Model-based Drug Discovery & Development, ADMET Property Estimation, QSAR Modeling & Analysis, QSP/QST modeling, On-site Training, Quantitative Systems Toxicology, End-to-End in silico solutions, Pharmacometrics, NCA PK Reporting, Compartmental PK Reporting, Drug-Induced-Liver-Injury , Cloud-based Web Application KIWI, Non-Alcholic Fatty Liver Disease, in vitro Dissolution Method Design, in vitro Permeability, FREE Chemical Sketching Software, and PBTK Modeling & Analysis/Simulation
|
Open
|
42505 10th Street West
|
Lancaster
|
California
|
US
|
93534
|
|
Simulations Plus
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:slp
|
95827
|
Apr 18th, 2024 12:00AM
|
Simulations Plus, Inc.
|
9.3K
|
153.00
|
Open
|
|
Apr 18th, 2024 12:47AM
|
Apr 18th, 2024 06:59PM
|
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
For more information visit us at www.simulations-plus.com
|
Open
|
Modeling & Simulation Software and Consulting Services, ADME-Tox Screening, Data Mining, Library Design, PBPK/PD Modeling & IVIVCs, Drug-Drug Interactions & Virtual Population Trials, Nonlinear Metabolism/Transport &Metabolite Tracking, PK/PD Modeling and Simulation, PBPK Modeling & Simulation, Drug Development, Regulatory Writing, Quantitative Systems Pharmacology, Clinical Pharmacology, Model-based Drug Discovery & Development, ADMET Property Estimation, QSAR Modeling & Analysis, QSP/QST modeling, On-site Training, Quantitative Systems Toxicology, End-to-End in silico solutions, Pharmacometrics, NCA PK Reporting, Compartmental PK Reporting, Drug-Induced-Liver-Injury , Cloud-based Web Application KIWI, Non-Alcholic Fatty Liver Disease, in vitro Dissolution Method Design, in vitro Permeability, FREE Chemical Sketching Software, and PBTK Modeling & Analysis/Simulation
|
Open
|
42505 10th Street West
|
Lancaster
|
California
|
US
|
93534
|
|
Simulations Plus
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:slp
|
95827
|
Apr 17th, 2024 12:00AM
|
Simulations Plus, Inc.
|
9.3K
|
153.00
|
Open
|
|
Apr 17th, 2024 12:02AM
|
Apr 17th, 2024 03:25PM
|
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
For more information visit us at www.simulations-plus.com
|
Open
|
Modeling & Simulation Software and Consulting Services, ADME-Tox Screening, Data Mining, Library Design, PBPK/PD Modeling & IVIVCs, Drug-Drug Interactions & Virtual Population Trials, Nonlinear Metabolism/Transport &Metabolite Tracking, PK/PD Modeling and Simulation, PBPK Modeling & Simulation, Drug Development, Regulatory Writing, Quantitative Systems Pharmacology, Clinical Pharmacology, Model-based Drug Discovery & Development, ADMET Property Estimation, QSAR Modeling & Analysis, QSP/QST modeling, On-site Training, Quantitative Systems Toxicology, End-to-End in silico solutions, Pharmacometrics, NCA PK Reporting, Compartmental PK Reporting, Drug-Induced-Liver-Injury , Cloud-based Web Application KIWI, Non-Alcholic Fatty Liver Disease, in vitro Dissolution Method Design, in vitro Permeability, FREE Chemical Sketching Software, and PBTK Modeling & Analysis/Simulation
|
Open
|
42505 10th Street West
|
Lancaster
|
California
|
US
|
93534
|
|
Simulations Plus
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:slp
|
95827
|
Apr 16th, 2024 12:00AM
|
Simulations Plus, Inc.
|
9.3K
|
153.00
|
Open
|
|
Apr 15th, 2024 11:58PM
|
Apr 16th, 2024 11:41AM
|
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
For more information visit us at www.simulations-plus.com
|
Open
|
Modeling & Simulation Software and Consulting Services, ADME-Tox Screening, Data Mining, Library Design, PBPK/PD Modeling & IVIVCs, Drug-Drug Interactions & Virtual Population Trials, Nonlinear Metabolism/Transport &Metabolite Tracking, PK/PD Modeling and Simulation, PBPK Modeling & Simulation, Drug Development, Regulatory Writing, Quantitative Systems Pharmacology, Clinical Pharmacology, Model-based Drug Discovery & Development, ADMET Property Estimation, QSAR Modeling & Analysis, QSP/QST modeling, On-site Training, Quantitative Systems Toxicology, End-to-End in silico solutions, Pharmacometrics, NCA PK Reporting, Compartmental PK Reporting, Drug-Induced-Liver-Injury , Cloud-based Web Application KIWI, Non-Alcholic Fatty Liver Disease, in vitro Dissolution Method Design, in vitro Permeability, FREE Chemical Sketching Software, and PBTK Modeling & Analysis/Simulation
|
Open
|
42505 10th Street West
|
Lancaster
|
California
|
US
|
93534
|
|
Simulations Plus
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:slp
|
95827
|
Apr 15th, 2024 12:00AM
|
Simulations Plus, Inc.
|
9.3K
|
153.00
|
Open
|
|
Apr 14th, 2024 11:54PM
|
Apr 15th, 2024 05:23PM
|
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
For more information visit us at www.simulations-plus.com
|
Open
|
Modeling & Simulation Software and Consulting Services, ADME-Tox Screening, Data Mining, Library Design, PBPK/PD Modeling & IVIVCs, Drug-Drug Interactions & Virtual Population Trials, Nonlinear Metabolism/Transport &Metabolite Tracking, PK/PD Modeling and Simulation, PBPK Modeling & Simulation, Drug Development, Regulatory Writing, Quantitative Systems Pharmacology, Clinical Pharmacology, Model-based Drug Discovery & Development, ADMET Property Estimation, QSAR Modeling & Analysis, QSP/QST modeling, On-site Training, Quantitative Systems Toxicology, End-to-End in silico solutions, Pharmacometrics, NCA PK Reporting, Compartmental PK Reporting, Drug-Induced-Liver-Injury , Cloud-based Web Application KIWI, Non-Alcholic Fatty Liver Disease, in vitro Dissolution Method Design, in vitro Permeability, FREE Chemical Sketching Software, and PBTK Modeling & Analysis/Simulation
|
Open
|
42505 10th Street West
|
Lancaster
|
California
|
US
|
93534
|
|
Simulations Plus
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:slp
|
95827
|
Apr 14th, 2024 12:00AM
|
Simulations Plus, Inc.
|
9.3K
|
153.00
|
Open
|
|
Apr 13th, 2024 11:42PM
|
Apr 13th, 2024 11:42PM
|
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
For more information visit us at www.simulations-plus.com
|
Open
|
Modeling & Simulation Software and Consulting Services, ADME-Tox Screening, Data Mining, Library Design, PBPK/PD Modeling & IVIVCs, Drug-Drug Interactions & Virtual Population Trials, Nonlinear Metabolism/Transport &Metabolite Tracking, PK/PD Modeling and Simulation, PBPK Modeling & Simulation, Drug Development, Regulatory Writing, Quantitative Systems Pharmacology, Clinical Pharmacology, Model-based Drug Discovery & Development, ADMET Property Estimation, QSAR Modeling & Analysis, QSP/QST modeling, On-site Training, Quantitative Systems Toxicology, End-to-End in silico solutions, Pharmacometrics, NCA PK Reporting, Compartmental PK Reporting, Drug-Induced-Liver-Injury , Cloud-based Web Application KIWI, Non-Alcholic Fatty Liver Disease, in vitro Dissolution Method Design, in vitro Permeability, FREE Chemical Sketching Software, and PBTK Modeling & Analysis/Simulation
|
Open
|
42505 10th Street West
|
Lancaster
|
California
|
US
|
93534
|
|
Simulations Plus
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:slp
|
95827
|
Apr 13th, 2024 12:00AM
|
Simulations Plus, Inc.
|
9.3K
|
153.00
|
Open
|
|
Apr 12th, 2024 11:34PM
|
Apr 13th, 2024 12:08PM
|
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
For more information visit us at www.simulations-plus.com
|
Open
|
Modeling & Simulation Software and Consulting Services, ADME-Tox Screening, Data Mining, Library Design, PBPK/PD Modeling & IVIVCs, Drug-Drug Interactions & Virtual Population Trials, Nonlinear Metabolism/Transport &Metabolite Tracking, PK/PD Modeling and Simulation, PBPK Modeling & Simulation, Drug Development, Regulatory Writing, Quantitative Systems Pharmacology, Clinical Pharmacology, Model-based Drug Discovery & Development, ADMET Property Estimation, QSAR Modeling & Analysis, QSP/QST modeling, On-site Training, Quantitative Systems Toxicology, End-to-End in silico solutions, Pharmacometrics, NCA PK Reporting, Compartmental PK Reporting, Drug-Induced-Liver-Injury , Cloud-based Web Application KIWI, Non-Alcholic Fatty Liver Disease, in vitro Dissolution Method Design, in vitro Permeability, FREE Chemical Sketching Software, and PBTK Modeling & Analysis/Simulation
|
Open
|
42505 10th Street West
|
Lancaster
|
California
|
US
|
93534
|
|
Simulations Plus
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:slp
|
95827
|
Apr 12th, 2024 12:00AM
|
Simulations Plus, Inc.
|
9.3K
|
153.00
|
Open
|
|
Apr 11th, 2024 11:41PM
|
Apr 12th, 2024 09:03AM
|
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
For more information visit us at www.simulations-plus.com
|
Open
|
Modeling & Simulation Software and Consulting Services, ADME-Tox Screening, Data Mining, Library Design, PBPK/PD Modeling & IVIVCs, Drug-Drug Interactions & Virtual Population Trials, Nonlinear Metabolism/Transport &Metabolite Tracking, PK/PD Modeling and Simulation, PBPK Modeling & Simulation, Drug Development, Regulatory Writing, Quantitative Systems Pharmacology, Clinical Pharmacology, Model-based Drug Discovery & Development, ADMET Property Estimation, QSAR Modeling & Analysis, QSP/QST modeling, On-site Training, Quantitative Systems Toxicology, End-to-End in silico solutions, Pharmacometrics, NCA PK Reporting, Compartmental PK Reporting, Drug-Induced-Liver-Injury , Cloud-based Web Application KIWI, Non-Alcholic Fatty Liver Disease, in vitro Dissolution Method Design, in vitro Permeability, FREE Chemical Sketching Software, and PBTK Modeling & Analysis/Simulation
|
Open
|
42505 10th Street West
|
Lancaster
|
California
|
US
|
93534
|
|
Simulations Plus
|
Health Care
|
Health Care Equipment & Services
|